Clinical utility and value contribution of an MRI-positive line marker for image-guided brachytherapy in gynecologic malignancies
The purpose of this study was to investigate the utility of a novel MRI-positive line marker, composed of C4:S (cobalt chloride –based contrast agent) encapsulated in high-density polyethylene tubing, in permitting dosimetry and treatment planning directly on MRI.
Source: Brachytherapy - Category: Cancer & Oncology Authors: Matthew S. Ning, Sastry Vedam, Jingfei Ma, R. Jason Stafford, Teresa L. Bruno, Mandy Cunningham, Christine Starks, Ann Lawyer, Aradhana M. Venkatesan, Li Wang, Jihong Wang, Nicholas D. Olivieri, Alexis B. Guzman, James R. Incalcaterra, Nikhil G. Thaker, M Source Type: research
More News: Brachytherapy | Cancer & Oncology | Chloride | Cobalt | Legislation | Medical Law | Study